Jamil Harbieh, Physician Assistant Medicare: Medicare Enrolled Practice Location: 1705 S. Tarboro, Wilson, NY 27893 Phone: 800-291-4020 Fax: 919-419-7247 |
News Archive
Acute myeloid leukemia (AML) is an aggressive cancer known for drug resistance and relapse. In an effort to uncover new treatment strategies, researchers at University of California San Diego School of Medicine and Moores Cancer Center discovered that a cell surface molecule known as CD98 promotes AML.
Physical activity is an important health behaviour for many diseases but its role in cancer control has been understudied and underappreciated. This book, edited by Kerry S. Courneya and Christine M. Friedenreich, explores in depth the relation between physical activity and cancer control, including primary prevention, coping with treatments, recovery after treatments, long-term survivorship, secondary prevention, and survival.
SATAI (www.satai.us) and the South Texas Regional Center of Innovation and Commercialization (www.strcic.com) today announced an investment of $1.045 million in Azaya Therapeutics, Inc. through the Texas Emerging Technology Fund (ETF) for the commercialization of Azaya's proprietary Protein Stabilized Nanoparticle (PSN) technology platform to produce targeted, safer and more effective formulations of chemotherapy pharmaceuticals for the treatment of cancer.
The University of Texas at San Antonio (UTSA) has received a five-year, $2.7 million grant from the National Science Foundation (NSF) to study nanomaterials and their biomedical applications.
Spectrum Health Innovations has signed a licensing agreement with Min-Bio, LLC, of Lowell, Mich. to manufacture a new trauma surgery basin that is a cut above existing designs.
› Verified 3 days ago